ABCC5 and nasopharyngeal carcinoma: Paclitaxel is a chemotherapeutic drug against neck and head cancer. Fork headbox (FOX) molecules are responsible for paclitaxel drug resistance. A molecular study reveals that ABCC5 with FOXM1 was highly expressed in nasopharyngeal carcinoma cells that were paclitaxel-resistant. ABCC5 gene transcription is controlled by binding of FOXM1 at the FHK consent pattern of the promoter